Beijing LabTech Instruments (688056.SH) has announced a forecasted increase, with an estimated net profit of 40 to 43 million yuan in 2024, an increase of 45.12% to 56.01% year-on-year.

22/01/2025

GMT Eight

Beijing LabTech Instruments (688056.SH) announced that the company is expected to achieve a net profit attributable to the owners of the parent company of 40 to 43 million yuan in the year 2024. Compared with the same period last year (legally disclosed data), this represents an increase of 12.4375 million to 15.4375 million yuan, an increase of 45.12% to 56.01% year-on-year.

HK Stock Market Move | OSL GROUP (00863) rose more than 3% in the final trading session, completing the acquisition of a licensed cryptocurrency trading platform in Japan to expand its global digital asset business.

Harbin Pharmaceutical Group (600664.SH): Cefuroxime Sodium for Injection passes generic drug consistency evaluation.

Contact: contact@gmteight.com

Beijing LabTech Instruments (688056.SH) has announced a forecasted increase, with an estimated net profit of 40 to 43 million yuan in 2024, an increase of 45.12% to 56.01% year-on-year.

RECOMMEND

CT Enterprise (03839) announces profit growth, with estimated annual shareholders' net profit expected to increase to approximately 11 million US dollars year-on-year.

Jiangsu Kuangshun Photosensitivity New-Material Stock (300537.SZ) predicts a net loss of 16 to 32 million yuan for the year 2024, turning from profit to loss.

Ningbo Cixing (300307.SZ) announced an expected increase, with an estimated net profit of 285 million to 330 million yuan for the year 2024, a year-on-year growth of 149.84% to 189.29%.